Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Structure Therapeutics reported Phase 2 data in March 2026 from its aleniglipron programme showing weight loss of up to 16.3% at 44 weeks, the highest efficacy yet reported for an oral small-molecule GLP-1 receptor agonist at that time point
CVS Health Analytics, 2023
Vaccine 32, 35733576
The sequence corresponds to a fragment originally identified within a larger protein derived from gastric tissue, and it is studied as an isolated peptide with consistent physicochemical characteristics
US$ 22.69
US$ 24.45
US$ 21.48
US$ 21.21
US$ 21.23
US$ 21.09
US$ 24.67
US$ 26.41
US$ 28.00
US$ 23.24
